Financials
- Market Capitalization 26.51 M
- Employee 1
- Founded N/A
- CEO N/A
- Website www.therapeuticsmd.com
- Headquarter Nevada, United States
- FIGI BBG000LKB954
- Industry Drug Manufacturers—Specialty & Generic
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 4375 | CPHI China Pharma Holdings, Inc. Common Stock | 0.89 USD | -3.26% | -13.59% | -29.92% | +34.62% | 38.29 M USD | ||
| 4448 | RMTI Rockwell Medical, Inc. - Common Stock | 7.75 USD | -2.15% | +2.38% | +17.07% | +287.50% | 31.24 M USD | ||
| 4509 | AYTU Aytu BioPharma, Inc. - Common Stock | 2.24 USD | -2.18% | -5.08% | +3.70% | -4.68% | 24.04 M USD | ||
| 4537 | BFRI Biofrontera Inc. - Common Stock | 1.49 USD | -2.61% | +0.68% | +33.04% | +71.26% | 22.13 M USD |
Frequently asked questions about TherapeuticsMD, Inc.
What is the TherapeuticsMD, Inc. stock price today?
The current price of TherapeuticsMD, Inc. (TXMD) is 2.29. Over the past 24 hours, the stock has changed by -2.63%. Follow the TXMD chart for real-time price dynamics.
What is the stock ticker of TherapeuticsMD, Inc.?
TherapeuticsMD, Inc. trades under the ticker TXMD. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is TherapeuticsMD, Inc. stock going up?
TXMD has changed by +12.25% over the last week, +10.63% over the last month, and +108.18% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of TherapeuticsMD, Inc.?
TherapeuticsMD, Inc. currently has a market capitalization of 26.51 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were TherapeuticsMD, Inc. earnings last quarter?
Last quarter, TherapeuticsMD, Inc. reported earnings of 0.01 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was TherapeuticsMD, Inc. revenue for the last quarter?
TherapeuticsMD, Inc. reported quarterly revenue of 869 K. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was TherapeuticsMD, Inc. net income for the last quarter?
TherapeuticsMD, Inc. reported net income of 155 K for the last quarter. The previous quarter showed 95 K, which means net income changed by +63.16%.
How many employees does TherapeuticsMD, Inc. have?
As of the latest available data, TherapeuticsMD, Inc. has 1 employees. Workforce size can provide additional context about the company's scale and operations.
What is TherapeuticsMD, Inc. EBITDA?
TherapeuticsMD, Inc. EBITDA is -721 K, and its EBITDA margin is -82.97%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy TherapeuticsMD, Inc. stock?
You can buy TherapeuticsMD, Inc. (TXMD) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in TherapeuticsMD, Inc. stock?
Investing in TherapeuticsMD, Inc. requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the TXMD chart and related analysis on metatrader.com as part of your research.